The DOI matches its Crossref record; 135 of the 136 references it cites were found in a registry or an index.
p53 and E2f: partners in life and death
Abstract
During tumour development cells sustain mutations that disrupt normal mechanisms controlling proliferation. Remarkably, the Rb-E2f and MDM2-p53 pathways are both defective in most, if not all, human tumours, which underscores the crucial role of these pathways in regulating cell cycle progression and viability. A simple interpretation of the observation that both pathways are deregulated is that they function independently in the control of cell fate. However, a large body of evidence indicates that, in addition to their independent effects on cell fate, there is extensive crosstalk between these two pathways, and specifically between the transcription factors E2F1 and p53, which influences vital cellular decisions. This Review discusses the molecular mechanisms that underlie the intricate interactions between E2f and p53.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“E2F1 signals positive and negative feedback to p53.225”
From Census and evaluation of p53 target genes (2017) · cites this paper as [225]
Citations
Cites
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063
Network motifs: theory and experimental approaches
Alon, U. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2102 · Cited by 3,279
Live or let die: the cell's response to p53
Vousden, K. H., & Lü, X. (2002) · Nature reviews. Cancer · doi:10.1038/nrc864 · Cited by 3,231
A microRNA component of the p53 tumour suppressor network
He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., et al. (2007) · Nature · doi:10.1038/nature05939 · Cited by 2,692
PUMA, a Novel Proapoptotic Gene, Is Induced by p53
Nakano, K., & Vousden, K. H. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00214-3 · Cited by 2,315
Noxa, a BH3-Only Member of the Bcl-2 Family and Candidate Mediator of p53-Induced Apoptosis
Oda, E., Ohki, R., Murasawa, H., Nemoto, J., Shibue, T., Yamashita, T., Tokino, T., Taniguchi, T., & Tanaka, †. N. (2000) · Science · doi:10.1126/science.288.5468.1053 · Cited by 2,112
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
Luo, J., Nikolaev, A. Y., Imai, S.-I., Chen, D., Su, F., Shiloh, A., Guarente, L., & Gu, W. (2001) · Cell · doi:10.1016/s0092-8674(01)00524-4 · Cited by 2,081
Tumor spectrum analysis in p53-mutant mice
Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., & Weinberg, R. A. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00002-6 · Cited by 2,051
Activation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042
Flagged first, then by citations
1 of the 136 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 495
van Harten, A. M., & Brakenhoff, R. H. (2021) · Cancers · doi:10.3390/cancers13112774 · Cited by 33
Genetic Aberrations and Interaction of NEK2 and TP53 Accelerate Aggressiveness of Multiple Myeloma
Feng, X., Guo, J., An, G., Wu, Y., Liu, Z., Meng, B., He, N., Zhao, X., Chen, S., Zhu, Y., et al. (2022) · Advanced Science · doi:10.1002/advs.202104491 · Cited by 31
Deregulated E2F Activity as a Cancer-Cell Specific Therapeutic Tool
Nakajima, R., Zhao, L., Zhou, Y., Shirasawa, M., Uchida, A., Murakawa, H., Fikriyanti, M., Iwanaga, R., Bradford, A. P., Araki, K., et al. (2023) · Genes · doi:10.3390/genes14020393 · Cited by 32
Hu, B., Shen, K., An, H., Wu, Y., & Du, Q. (2011) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2010.0853 · Cited by 30
Nath, S., Chowdhury, A., Dey, S., Roychoudhury, A., Ganguly, A., Bhattacharyya, D., & Roychoudhury, S. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00868-14 · Cited by 30
Zhao, J., Ren, K., & Tang, J. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.10.005 · Cited by 30
Liu, Y., Zhang, X., Zhou, S., Shi, J., Xu, Y. L., He, J., Feng, L., Wei, A., Zhou, L., & Chen, Z. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14055 · Cited by 30
Yi, Y., Polosukhina, D., Love, H. D., Hembd, A., Pickup, M. W., Moses, H. L., Lovvorn, H. N., Zent, R., & Clark, P. E. (2015) · The Journal of Urology · doi:10.1016/j.juro.2015.04.090 · Cited by 29
González‐Gironès, D. M., Moncunill‐Massaguer, C., Iglesias‐Serret, D., Cosialls, A. M., Pérez‐Perarnau, A., Palmeri, C. M., Rubio‐Patiño, C., Villunger, A., Pons, G., & Gil, J. (2013) · APOPTOSIS · doi:10.1007/s10495-013-0850-6 · Cited by 30
Dynamics of P53 in response to DNA damage: Mathematical modeling and perspective
Sun, T., & Cui, J. (2015) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2015.08.017 · Cited by 29
Wyżewski, Z., Mielcarska, M. B., Gregorczyk-Zboroch, K. P., & Myszka, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137265 · Cited by 30
Ye, B., Chen, P., Lin, C., Zhang, C., & Li, L. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116815 · Cited by 28
Pitman, R. T., Wojdyla, L. M., & Puri, N. (2013) · Oncotarget · doi:10.18632/oncotarget.1047 · Cited by 29
Loss of MAP3K1 enhances proliferation and apoptosis during retinal development
Mongan, M., Wang, J., Liu, H., Fan, Y., Jin, C., Kao, W. Y., & Xia, Y. (2011) · Development · doi:10.1242/dev.065003 · Cited by 30
Yang, B., WANG, L., Luo, X., Chen, L., Yang, Z., & Liu, L. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2768 · Cited by 28
Kuczyk, M. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1367 · Cited by 28
He, T., Guo, J., Song, H., Zhu, H., Di, X., Min, H., Wang, Y., Chen, G., Dai, W., Ma, J., et al. (2017) · Pathology & Oncology Research · doi:10.1007/s12253-017-0215-5 · Cited by 28
Modeling the response of a tumor-suppressive network to mitogenic and oncogenic signals
Tian, X., Huang, B. Y., Zhang, X., Lu, M., Liu, F., Onuchic, J. N., & Wang, W. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1702412114 · Cited by 28
Aydın, Y., Chedid, M., Chava, S. P., Williams, D. D., Liu, S., Hagedorn, C. H., Sumitran–Holgersson, S., Reiss, K., Moroz, K., Lu, H., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10087-6 · Cited by 28
RetractedYe, Y., Gao, L., & Zhang, S. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz201 · Cited by 27
Wang, B., Li, D., Sidler, C. L., Rodriguez‐Juarez, R., Singh, N., Heyns, M., Ilnytskyy, Y., Bronson, R. T., & Kovalchuk, O. (2015) · Oncotarget · doi:10.18632/oncotarget.3157 · Cited by 27
Khan, F. M., Schmitz, U., Nikolov, S. G., Engelmann, D., Pützer, B. M., Wolkenhauer, O., & Vera, J. (2013) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2013.05.007 · Cited by 27
Jiao, J., Niu, W., Wang, Y., Baggerly, K., Ye, Y., Wu, X., Davenport, D., Almeda, J. L., Betancourt-Garcia, M. M., Forse, R. A., et al. (2017) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-17-0235 · Cited by 27
Generation of knockout mice using engineered nucleases
Sung, Y. H., Jin, Y., Kim, S., & Lee, H. (2014) · Methods · doi:10.1016/j.ymeth.2014.02.009 · Cited by 27
Transcription factors and cognate signalling cascades in the regulation of autophagy
Chandra, V., Bhagyaraj, E., Parkesh, R., & Gupta, P. (2016) · Biological Reviews · doi:10.1111/brv.12177 · Cited by 26
YAP-driven malignant reprogramming of oral epithelial stem cells at single cell resolution
Faraji, F., Ramirez, S. I., Clubb, L. M., Sato, K., Burghi, V., Hoang, T. S., Officer, A., Quiroz, P. Y. A., Galloway, W. M. G., Mikulski, Z., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-55660-6 · Cited by 28
The miRNA network: micro-regulator of cell signaling in cancer
Mei, Q., Li, X., Guo, M., Fu, X., & Han, W. (2014) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2014.953935 · Cited by 26
Zacksenhaus, E., Liu, J.-K., Jiang, Z., Yao, Y., Xia, L., Shrestha, M., & Ben‐David, Y. (2016) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2016.10.003 · Cited by 28
Carper, M. B., Denvir, J., Bošković, G., Primerano, D. A., & Claudio, P. P. (2014) · Genes & Cancer · doi:10.18632/genesandcancer.43 · Cited by 26
Bucha, S., Mukhopadhyay, D., & Bhattacharyya, N. P. (2019) · FEBS Journal · doi:10.1111/febs.14980 · Cited by 26
Antiproliferative effect of D-glucuronyl C5-epimerase in human breast cancer cells
Prudnikova, T. Y., Mostovich, L. A., Доманицкая, Н. В., Pavlova, T. V., Kashuba, V. I., Zabarovsky, E. R., & Витальевна, Г. Э. (2010) · Cancer Cell International · doi:10.1186/1475-2867-10-27 · Cited by 26
Identifying module biomarkers from gastric cancer by differential correlation network
Liu, X., & Chang, X. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s113281 · Cited by 25
Advances in the targeted therapy of liposarcoma
Guan, Yu, X., Wang, H., Wang, H., Zhang, J., Li, G., Cao, J., & Teng, L. (2015) · OncoTargets and Therapy · doi:10.2147/ott.s72722 · Cited by 25
Valproic acid suppresses Warburg effect and tumor progression in neuroblastoma
Fang, E., Wang, J., Hong, M., Zheng, L., & Tong, Q. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.11.103 · Cited by 25
Ma, Z., Zhu, T., Wang, H., Wang, B., Fu, L., & Yu, G. (2023) · Current Molecular Pharmacology · doi:10.2174/1874467216666230306101653 · Cited by 24
Jiang, X., Wang, T., Zhao, B. X., Sun, H., Dong, Y., Ma, Y., Li, Z., Wu, Y., Wang, K., Guan, X., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.101966 · Cited by 26
Zhang, C., Min, L., Zhang, L.-Y., Ma, Y., Yang, Y., & Shou, C. (2015) · Tumor Biology · doi:10.1007/s13277-015-3938-5 · Cited by 24
A novel oncoprotein Pirh2: rising from the shadow of MDM2
Wang, Z., Yang, B. R., Dong, L., Peng, B., He, X., & Liu, W. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.01899.x · Cited by 24
CGGBP1 regulates cell cycle in cancer cells
Singh, U., Roswall, P., Uhrbom, L., & Westermark, B. (2011) · BMC Molecular Biology · doi:10.1186/1471-2199-12-28 · Cited by 24
Functions and epigenetic aspects of miR-15/16: Possible future cancer therapeutics
Ramaiah, M. J. (2018) · Gene Reports · doi:10.1016/j.genrep.2018.06.012 · Cited by 24
Lin, C.-H., Lee, H., Chang, W., Lee, F., Chen, L.-C., Lu, L., & Lin, Y. (2020) · Cancers · doi:10.3390/cancers12092690 · Cited by 24
Inhibitory effect of vitamin C on intrinsic aging in human dermal fibroblasts and hairless mice
Jeong, J.-H., Kim, M., Kim, C., & Hwang, J. (2017) · Food Science and Biotechnology · doi:10.1007/s10068-017-0252-6 · Cited by 25
Li, M., & Chen, C.-W. D. (2022) · Biomedicines · doi:10.3390/biomedicines10061325 · Cited by 23
Virus-induced host genomic remodeling dysregulates gene expression, triggering tumorigenesis
Dong, W., Wang, H., Li, M., Li, P., & Ji, S. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1359766 · Cited by 23
Bertin-Ciftci, J., Barré, B., Pen, J. L., Maillet, L., Couriaud, C., Juin, P. P., & Braun, F. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.6 · Cited by 23
Puri, N., Pitman, R. T., Mulnix, R. E., Erickson, T., Iness, A. N., Vitali, C., Zhao, Y., & Salgia, R. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.09.010 · Cited by 23
MicroRNAs in human glioblastoma from bench to beside
Chen, J. (2015) · Frontiers in bioscience · doi:10.2741/4300 · Cited by 23
E2F1 regulates testicular descent and controls spermatogenesis by influencing WNT4 signaling
Jorgez, C. J., Seth, A., Wilken, N., Bournat, J. C., Chen, C. H., & Lamb, D. J. (2021) · Development · doi:10.1242/dev.191189 · Cited by 23
Sharawi, Z. W. (2020) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-020-02947-y · Cited by 23
RetractedCao, M., Zou, X., Li, C., Lin, Z., Wang, N., Zou, Z., Ye, Y., Seemann, J., Levine, B., Tang, Z., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37340-z · Cited by 22
Yan, F., Liu, H., & Liu, Z. (2013) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2013.06.022 · Cited by 22
Cui, C., Jia, Q., Deng, Q., Chen, R., Zhai, D., & Yu, J. (2016) · BioMed Research International · doi:10.1155/2016/1804137 · Cited by 22
Aubrecht, T. G., Faden, A. I., Sabirzhanov, B. E., Glaser, E. P., Roelofs, B. A., Polster, B. M., Makarevich, O. D., & Stoica, B. A. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1156-y · Cited by 22
Gao, J., Shui, Y.-M., Jiang, W., Huang, E., Shou, Q., Ji, X., He, B., Lv, G., & He, T. (2016) · Oncotarget · doi:10.18632/oncotarget.12375 · Cited by 22
Wang, S., Wang, L., Sun, D., Chai, C., Hsi, E., Kuo, H., Yokoyama, K. K., & Hsu, S. (2016) · Oncotarget · doi:10.18632/oncotarget.9228 · Cited by 21
Nakajima, R., Deguchi, R., Komori, H., Zhao, L., Zhou, Y., Shirasawa, M., Angelina, A., Goto, Y., Tohjo, F., Nakahashi, K., et al. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.04.092 · Cited by 21
Identification of the Rage-dependent gene regulatory network in a mouse model of skin inflammation
Riehl, A., Bauer, T., Brors, B., Busch, H. S., Mark, R., Németh, J., Gebhardt, C., Bierhaus, A., Nawroth, P. P., Eils, R., et al. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-537 · Cited by 21
Carotid body growth during chronic postnatal hyperoxia
Dmitrieff, E. F., Piro, S. E., Broge, T. A., Dunmire, K. B., & Bavis, R. W. (2011) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2011.11.006 · Cited by 21
Regulating the genome surveillance system: miRNAs and the p53 super family
Bailey, S. G., Sánchez-Elsner, T., Stephanou, A., Cragg, M. S., & Townsend, P. A. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0456-1 · Cited by 22
MEF/ELF4 transactivation by E2F1 is inhibited by p53
Taura, M., Suico, M. A., Fukuda, R., Koga, T., Shuto, T., Sato, T., Morino‐Koga, S., Okada, S., & Kai, H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq762 · Cited by 21
Chan, W. H., Mohamad, M. S., Deris, S., Zaki, N., Kasim, S. B., Omatu, S., Corchado, J. M., & Alashwal, H. (2016) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2016.08.004 · Cited by 21
Heterogeneous Reciprocal Graphical Models
Ni, Y., Müller, P., Zhu, Y., & Ji, Y. (2017) · Biometrics · doi:10.1111/biom.12791 · Cited by 23
E2F1 acts as a negative feedback regulator of c-Myc-induced hTERT transcription during tumorigenesis
Zhang, Y., Zhang, A., Shen, C., Zhang, B., RAO, Z., Wang, R., Yang, S., Ning, S., Mao, G.-P., & Fang, D.-C. (2014) · Oncology Reports · doi:10.3892/or.2014.3287 · Cited by 21
TRIM-endous functional network of tripartite motif 29 (TRIM29) in cancer progression and beyond
Wu, Q., Nandi, D., & Sharma, D. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-024-10226-2 · Cited by 22
Thompson, T., Danilenko, M., Vassilev, L. T., & Studzinski, G. P. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.4.12366 · Cited by 20
Ei24-deficiency attenuates protein kinase Cα signaling and skin carcinogenesis in mice
Devkota, S., Sung, Y. H., Choi, J., Lee, J., Ha, N. Y., Kim, H., Cho, B. C., Song, J., & Lee, H. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.06.034 · Cited by 20
Rajasekaran, N., Jung, H. S., Bae, S. H., Chelakkot, C., Hong, S., Choi, J., Yim, D., Oh, Y., Choi, Y., & Shin, Y. K. (2017) · Neoplasia · doi:10.1016/j.neo.2017.07.005 · Cited by 20
Kim, H., Yi, S. S., Lee, H., Heo, T., Park, S., Jun, H. S., Song, K., & Kim, S. (2018) · Nutrition and Cancer · doi:10.1080/01635581.2018.1460673 · Cited by 20
Jiang, X., Nevins, J. R., Shats, I., & Chi, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127951 · Cited by 20
WANG, Z., Liu, X., Zhang, D., Wang, X., Zhao, F., Shi, P., & Pang, X. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2798 · Cited by 19
Association between TP53 Arg72Pro polymorphism and thyroid carcinoma risk
Wang, F., Wang, P., Wang, B., Fu, Z., Yuan, Y., Yan, S.-L., Zhao, W., & Wang, Y. (2013) · Tumor Biology · doi:10.1007/s13277-013-1359-x · Cited by 19
Coordination of miR-192 and miR-22 in p53-Mediated Cell Fate Decision
Sun, C., Zhang, X., & Wang, W. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194768 · Cited by 19
Zhang, K., Zhang, B., Bai, Y., & Dai, L. (2019) · Journal of Cancer · doi:10.7150/jca.33983 · Cited by 19
Gong, W., Gohla, R. M., Bowlin, K. M., Koyano‐Nakagawa, N., Garry, D. J., & Shi, X. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.629956 · Cited by 19
Comprehensive Bioinformatic Investigation of TP53 Dysregulation in Diverse Cancer Landscapes
Khan, R., Puszyński, K., & Kozłowska, E. (2024) · Genes · doi:10.3390/genes15050577 · Cited by 19
S-phase-coupled apoptosis in tumor suppression
Cho, Y., & Liang, P. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0666-x · Cited by 19
E2F1 inhibits MDM2 expression in a p53-dependent manner
Tian, X., Chen, Y., Hu, W., & Wu, M. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.09.003 · Cited by 18
Brondello, J., Prieur, A., Philipot, D., Lemaı̂tre, J.-M., Lenaers, G., Piette, J., & Dulić, V. (2012) · médecine/sciences · doi:10.1051/medsci/2012283017 · Cited by 28
Malhotra, S., Winans, S., Lam, G., Justice, J., Morgan, R. W., & BEEMON, K. L. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006708 · Cited by 19
Komori, H., Goto, Y., Kurayoshi, K., Ozono, E., Iwanaga, R., Bradford, A. P., Araki, K., & Ohtani, K. (2018) · Scientific Reports · doi:10.1038/s41598-018-26860-0 · Cited by 18
Levandowski, C. B., Jones, T., Gruca, M. A., Ramamoorthy, S., Dowell, R. D., & Taatjes, D. J. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3001364 · Cited by 18
Condiotti, R., Goldenberg, D., Giladi, H., Perlman, T. S., Waddington, S. N., Buckley, S. M. K., Heim, D., Cheung, W., Themis, M., Coutelle, C., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.193 · Cited by 18
Ei24, a Novel E2F Target Gene, Affects p53-independent Cell Death upon Ultraviolet C Irradiation
Sung, Y. H., Jin, Y., Kang, Y., Devkota, S., Lee, J., Roh, J.-I., & Lee, H. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.477570 · Cited by 17
Recent translational research into targeted therapy for liposarcoma
Patel, R. B., Li, T., Liao, Z., Jaldeepbhai, J. A., Perera, H. A. P. N. V., Muthukuda, S. K., Dhirubhai, D. H., Singh, V. P., Du, X., & Yang, J. (2017) · Stem Cell Investigation · doi:10.21037/sci.2017.02.09 · Cited by 17
Regulation of Plant Immunity by Nuclear Membrane-Associated Mechanisms
Fang, Y., & Gu, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.771065 · Cited by 17
MDM2 Overexpression, Activation of Signaling Networks, and Cell Proliferation
Deb, S. P., Singh, S., & Deb, S. (2014) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-017-9211-0_12 · Cited by 18
microRNAs with AAGUGC seed motif constitute an integral part of an oncogenic signaling network
Zhou, Y., Frings, O., Branca, R. M., Boekel, J., le Sage, C., Fredlund, E., Agami, R., & Orre, L. M. (2016) · Oncogene · doi:10.1038/onc.2016.242 · Cited by 17
Li, Y., Sturgis, E. M., Zhu, L., Cao, X., Wei, Q., Zhang, H., & Li, G. (2016) · Molecular Carcinogenesis · doi:10.1002/mc.22595 · Cited by 17
Chen, B., Wen, P., Hu, G., Gao, Y., Qi, X., Zhu, K., Chen, S., Wu, L., Xu, A., & Zhao, G. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00408 · Cited by 17
VentX trans-Activates p53 and p16ink4a to Regulate Cellular Senescence
Wu, X., Gao, H., Ke, W., Hager, M. H., Xiao, S., Freeman, M. R., & Zhu, Z. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.206078 · Cited by 17
Restoration of p53 Functions Protects Cells from Concanavalin A–Induced Apoptosis
Amin, A. R. M. R., Thakur, V. S., Gupta, K., Jackson, M. W., Harada, H., Agarwal, M. K., Shin, D. M., Wald, D. N., & Agarwal, M. L. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0732 · Cited by 18
Scalia, P., Williams, S. J., Fujita‐Yamaguchi, Y., & Giordano, A. (2022) · Cell Cycle · doi:10.1080/15384101.2022.2108117 · Cited by 17
Manickavinayaham, S., Singh, A. K., & Kumar, V. (2013) · Journal of Cell Science · doi:10.1242/jcs.126235 · Cited by 16
Yuan, Y., Sturgis, E. M., Zhu, L., Lü, M., Li, Y., Wei, Q., & Li, G. (2016) · Molecular Carcinogenesis · doi:10.1002/mc.22576 · Cited by 16
Tennen, R. I., Haye, J. E., Wijayatilake, H. D., Arlow, T., Ponzio, D. Y., & Gammie, A. E. (2012) · DNA repair · doi:10.1016/j.dnarep.2012.11.002 · Cited by 17
Matsumoto, A., Takeishi, S., & Nakayama, K. I. (2014) · Blood · doi:10.1182/blood-2013-10-532390 · Cited by 16
Reconstructing transcription factor activities in hierarchical transcription network motifs
Ocone, A., & Sanguinetti, G. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr487 · Cited by 16
Interplay between p53 and VEGF: how to prevent the guardian from becoming a villain
Haupt, S., Gamell, C., Wolyniec, K., & Haupt, Y. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.51 · Cited by 16
LncRNA LIMp27 Regulates the DNA Damage Response through p27 in p53‐Defective Cancer Cells
La, T., Chen, S., Zhao, X. H., Zhou, S. F., Xu, R., Liu, T., Zhang, Y. Y., Ye, K., Xu, L., Guo, T., et al. (2023) · Advanced Science · doi:10.1002/advs.202204599 · Cited by 15
Cell Cycle Deregulation in Ewing's Sarcoma Pathogenesis
Kowalewski, A. A., Randall, R. L., & Lessnick, S. L. (2010) · Sarcoma · doi:10.1155/2011/598704 · Cited by 17
Metadata
- Authors
- Polager, S., & Ginsberg, D.
- Affiliations
- Bar-Ilan University (IL)
- Corresponding author
- Ginsberg, Doron
- ORCID
- Ginsberg, Doron
- Venue
- Nature Reviews Cancer
- Published
- 2009-10
- Volume
- 9
- Issue
- 10
- Pages
- 738-748
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2019562165
- Cited by
- 498
- References
- 136
- Citations by year
- 2026: 7 · 2025: 12 · 2024: 20 · 2023: 23 · 2022: 13 · 2021: 23 · 2020: 18 · 2019: 23 · 2018: 27 · 2017: 35 · 2016: 38 · 2015: 41 · 2014: 43 · 2013: 54 · 2012: 46
- FWCI
- 3.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- p53, E2F1, Rb/E2F pathway, MDM2-p53 pathway, pathway crosstalk, cell cycle regulation, cell fate, carcinogenesis, transcription factors, tumor suppressor
- MeSH terms
- Cell Cycle, Cell Survival, Humans, Mutation, Neoplasms, Signal Transduction, Tumor Suppressor Protein p53, Apoptosis, Cell Proliferation, E2F Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review